24:23
Grading of IDH‑mutant astrocytoma using diffusion, susceptibility & perfusion‑weighted imaging
CellTalk
29:52
Exploring the safety and efficacy of a novel drug combination for treating astrocytomas | CellTalk
21:31
Prognostic factors associated with survival in patients with diffuse astrocytoma | CellTalk
23:21
Expression of CD133 cancer stem cell marker in IDH-mutant and IDH-wild type astrocytoma | CellTalk
42:18
Multi-omic analysis of low-grade glioma histological subtypes uncovers significance of tumor purity
